CONMED Corp. (CNMD)
51.13
-0.81
(-1.56%)
USD |
NYSE |
Nov 10, 12:55
CONMED EPS Diluted (Quarterly) : 0.6571 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.6571 |
| June 30, 2026 | 0.766 |
| March 31, 2026 | 0.4516 |
| December 31, 2025 | 0.5394 |
| September 30, 2025 | 0.0921 |
| June 30, 2025 | 0.6898 |
| March 31, 2025 | 0.1938 |
| December 31, 2024 | 1.084 |
| September 30, 2024 | 1.574 |
| June 30, 2024 | 0.9637 |
| March 31, 2024 | 0.6302 |
| December 31, 2023 | 1.050 |
| September 30, 2023 | 0.4998 |
| June 30, 2023 | 0.4319 |
| March 31, 2023 | 0.0583 |
| December 31, 2022 | 0.8595 |
| September 30, 2022 | 1.484 |
| June 30, 2022 | -5.652 |
| March 31, 2022 | 0.4748 |
| December 31, 2021 | 0.746 |
| September 30, 2021 | 0.465 |
| June 30, 2021 | 0.4094 |
| March 31, 2021 | 0.3142 |
| December 31, 2020 | 0.8062 |
| September 30, 2020 | 0.2328 |
| Date | Value |
|---|---|
| June 30, 2020 | -0.96 |
| March 31, 2020 | 0.1995 |
| December 31, 2019 | 0.4895 |
| September 30, 2019 | 0.234 |
| June 30, 2019 | 0.1941 |
| March 31, 2019 | 0.0352 |
| December 31, 2018 | 0.5416 |
| September 30, 2018 | 0.2002 |
| June 30, 2018 | 0.30 |
| March 31, 2018 | 0.37 |
| December 31, 2017 | 1.65 |
| September 30, 2017 | 0.26 |
| June 30, 2017 | 0.22 |
| March 31, 2017 | -0.16 |
| December 31, 2016 | 0.24 |
| September 30, 2016 | 0.26 |
| June 30, 2016 | 0.10 |
| March 31, 2016 | -0.08 |
| December 31, 2015 | 0.28 |
| September 30, 2015 | 0.32 |
| June 30, 2015 | 0.27 |
| March 31, 2015 | 0.23 |
| December 31, 2014 | 0.41 |
| September 30, 2014 | 0.07 |
| June 30, 2014 | 0.37 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Globus Medical, Inc. | 1.038 |
| Becton, Dickinson & Co. | 2.540 |
| Abbott Laboratories | 0.5294 |
| AngioDynamics, Inc. | -0.1689 |
| Alphatec Holdings, Inc. | -0.0348 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 19.80M |
| Revenue (Quarterly) | 335.59M |
| Total Expenses (Quarterly) | 315.79M |
| Enterprise Value | 2.319B |
| Gross Profit Margin (Quarterly) | 10.53% |
| Profit Margin (Quarterly) | 5.90% |
| Earnings Yield | 4.72% |
| Operating Earnings Yield | 1.40% |
| Normalized Earnings Yield | 6.062 |